Illness	Number of cases
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	118
Non-follicular lymphoma (C83.3)	107
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00)	83
Viral infection of unspecified site - Coronavirus infection unspecified (B34.2)	74
Lymphoid leukaemia - Chronic lymphocytic leukemia of B-cell type not having achieved remission (C91.10)	59
Viral pneumonia not elsewhere classified (J12.8)	58
Malignant neoplasm of colon - Malignant neoplasm of sigmoid colon (C18.7)	36
Plasmodium falciparum malaria - Plasmodium falciparum malaria unspecified (B50.9)	33
Malignant neoplasm of bronchus and lung (C34.1)	33
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	30

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	943
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	417
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	317
(6-007.72)	287
Taking a tissue sample (biopsy) of the bone marrow without surgical incision (1-424)	260
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	210
Insertion or exchange of a tube (catheter) in a large vein (8-831.0)	166
(8-98g.00)	143
Comprehensive examination of blood cancer (1-941.0)	131
Cancer treatment for several days (e.g. 5-8 days) with two or more chemotherapy drugs administered into a vein (8-544)	129

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 0152 , 3752

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05
CQ02

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
197	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
132	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
129	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre Phase I/II studies
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Project-related cooperation with colleges and universities
Doctoral supervision
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB20	Nursing professional B. Sc.	In Kooperation mit Münchner Hochschulen
HB19	Nursing professionals	384 Plätze
HB17	Auxiliary nurse (m/f)	Wir bilden Pflegefachhelfer*innen aus (50 Plätze).
HB15	Anaesthesia technical assistant (m/f)	96 Plätze OTA und ATA
HB07	Surgical technical assistant (m/f)	96 Plätze OTA und ATA